Trades on 1 secondary market

Comanche Biopharma

Comanche Biopharma is a clinical-stage biopharmaceutical company based in Concord, Massachusetts, developing investigational siRNA (small interfering RNA) medicines for maternal health. Its lead candidate, CBP-4888, is a subcutaneously administered siRNA therapy targeting sFlt1-mediated preterm pree

minimal 11.9 / 100 0 APIs View provider profile →

Company Life Sciences Biopharmaceutical Biotechnology Maternal Health Preeclampsia

Comanche Biopharma is an API provider whose private shares are listed on 1 secondary market: Forge Global.

Where It Trades

F Forge Global View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.